Loading...

NeuroPace, Inc.

NPCENASDAQ
Healthcare
Medical - Devices
$8.98
$-0.09(-0.99%)

NeuroPace, Inc. (NPCE) Company Profile & Overview

Explore NeuroPace, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

NeuroPace, Inc. (NPCE) Company Profile & Overview

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

SectorHealthcare
IndustryMedical - Devices
CEOJoel D. Becker

Contact Information

650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

184 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;